TFDA-2024-0011-V011

Type IB variation for application TFDA-2024-0011. Type IB variation: Manufacturing Process Change for Infectivir — critical change

Variation Number
TFDA-2024-0011-V011
Type
Type IB
Application
TFDA-2024-0011
Change
CHG-2022-0011
Status
Approved
Fee
€2,976
Submitted
—
Approved
2024-03-29
Description

Type IB variation: Manufacturing Process Change for Infectivir — critical change